Suspendido

HIV-TBImpact of HIV Infection on Latent TB Among Patients With HIV-TB Co-infection

0 criterios cumplidosConsulta de un vistazo cómo tu perfil cumple con cada criterio de elegibilidad.
Qué se está recopilando

Colección de datos

Recopilados desde hoy en adelante - Prospectivo
Quiénes están siendo reclutados

Infecciones por Actinomicetales+18

+ Enfermedades Transmisibles

+ Enfermedades Urogenitales

De 18 a 65 años
Ver todos los criterios de elegibilidad
Cómo está diseñado el estudio

Observacional
Inicio del estudio: julio de 2008
Ver detalles del protocolo

Resumen

Patrocinador PrincipalMinistry of Science and Technology, India
Contacto del EstudioSurendra K Sharma, M.D., Ph.D
Última actualización: 27 de enero de 2026
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Fecha de inicio: 1 de julio de 2008

Fecha en la que se inscribió al primer participante.

During the natural course of HIV disease, emergence of opportunistic infection not only imposes morbidity on HIV-TB co-infected patients, but also facilitates viral replication causing faster disease progression. Tuberculosis, being the commonest among the opportunistic infections among HIV infected persons deserves special attention. Moreover, disruption of latency of TB infection (LTBI) with development of more severe clinical forms at relatively early stage of HIV disease when CD4 count still remains above 300/ul, makes TB a unique opportunistic infection and negatively influence the outcome of dual infection.This is suggestive of impairment of some critical immune function involving relatively less frequent fine T cell subsets with functional hierarchy over bulk T cells, so as to weaken the immune containment of LTBI resulting in reactivation of M. tuberculosis and manifestation of severe forms of TB.HIV has recently been reported to preferentially infect, destroy and incapacitate two key immune-regulatory T cell subsets, namely NKT and Treg cells.Therefore, studying them along the course of HIV disease and impact of their changes on the function of effector T cells directed against M.tuberculosis is important.

Título OficialImpact of HIV Infection on Latent TB Among Patients With HIV-TB Co-infection
NCT00692809
Patrocinador PrincipalMinistry of Science and Technology, India
Contacto del EstudioSurendra K Sharma, M.D., Ph.D
Última actualización: 27 de enero de 2026
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Protocolo

Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.
Detalles del Diseño

Se reclutarán 180 pacientes

Número total de participantes que el ensayo clínico espera reclutar.

Elegibilidad

Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.
Condiciones
Criterios

Cualquier sexo

Sexo biológico de los participantes elegibles para inscribirse.

De 18 a 65 años

Rango de edades de los participantes que pueden unirse al estudio.

Voluntarios sanos permitidos

Indica si personas sanas, sin la condición que se estudia, pueden participar.

Condiciones

Patología

Infecciones por ActinomicetalesEnfermedades TransmisiblesEnfermedades UrogenitalesSíndrome de Inmunodeficiencia AdquiridaInfecciones Transmitidas por la SangreInfección latenteEnfermedades GenitalesInfecciones Bacterianas y MicosisInfecciones bacterianasEnfermedades del sistema inmunitarioSíndromes de Deficiencia InmunológicaInfeccionesInfecciones por MicobacteriasInfecciones por RetroviridaeInfecciones por virus de ARNEnfermedades de Transmisión SexualEnfermedades por virus lentoTuberculosisEnfermedades ViralesEnfermedades de transmisión sexual, viralesInfecciones por VIH

Criterios

Inclusion Criteria: HIV infected +LTBI group: * Patient of either sex between 18-65 years of age * All the patients should be HIV ELISA test positive irrespective of CD4 count and presence of other opportunistic infections Antiretroviral drug naive HIV patients * No past history of TB * Patients should be either tuberculin test positive (\> 5mm) or interferon gamma release assay positive * Written informed consent to participate in the study given by participants or legal guardian * Patients able to comply with instructions and come back for a regular follow up HIV infected + Clinical TB group: * Patient of either sex between 18-65 years of age * All the patients should be HIV ELISA test positive irrespective of CD4 count and presence of other opportunistic infections * In PTB group, patient should be two sputum smear positive out of three consecutive samples * In EPTB group, diagnosis of TB will be: * Definitive -Culture confirmed * Probable -Histopathological or radiological -Clinical features and response to anti TB treatment (ATT) * Possible TB -Clinical feature and response to anti TB treatment (ATT) * Written informed consent to participate in the study given by participants or legal guardian * Patients able to comply with instructions and come back for a regular follow up HIV negative Clinical TB group: * Patients of either sex between 18-65 years of age who are permanent resident of Delhi * All patients should be HIV ELISA negative * In PTB group, patients should be two sputum smear positive (at least 1+) out of three consecutive samples * In EPTB group, diagnosis of TB will be: * Definitive -Culture-confirmed * Probable -Histopathological or radiological -Clinical features and response to anti-TB treatment (ATT) * Possible TB -Clinical features and response to anti-TB treatment (ATT) * Written informed consent to participate in the study given by participants or legal guardian * Patients able to comply with instructions and come back for a regular follow up Normal controls: * Persons of either sex between 18-65 years of age who are permanent resident of Delhi * Written informed consent to participate in the study given by participants or legal guardian * Person should not have past history of TB * Mantoux test negative (\< 10mm) * Chest-X-ray normal * Hemogram normal * Renal and liver functions normal * Hepatitis viral markers normal * No clinical evidence of malnutrition * HIV ELISA negative Exclusion Criteria: HIV infected +LTBI group: * Pregnant and lactating females * Patients who are getting steroid therapy * Transplant patients, diabetes mellitus or malignancy, chronic renal failure or liver diseases * Currently receiving cytotoxic therapy, or have received it within the last 3 months * Terminally ill as per treating clinician's judgment * Patient from outside Delhi and migrants HIV infected + Clinical TB group: * Category II and multidrug-resistant pulmonary tuberculosis * Pregnant and lactating females * Patients who are getting steroid therapy * Transplant patients, diabetes mellitus or malignancy, chronic renal failure or liver diseases * Currently receiving cytotoxic therapy, or have received it within the last 3 months * Terminally ill patient as per treating clinician's judgment * Patients from outside Delhi and migrants HIV negative Clinical TB group: * Category II and multi drug-resistant pulmonary tuberculosis * Patients who are getting steroid therapy * Transplant patients, diabetes mellitus or malignancy, chronic renal failure or liver disease * Currently receiving cytotoxic therapy, or have received it within the last 3 months * Terminally ill patient as per treating clinician's judgment * Patients unwilling to comply with the study procedures or those with history of alcohol or drug abuse Normal controls: * Transplant patients, diabetes mellitus or malignancy * Patients unwilling to comply with the study procedures or those with history of alcohol or drug abuse

Plan de Estudio

Conoce todos los tratamientos administrados en este estudio, su descripción detallada y en qué consisten.
Objetivos del Estudio

Objetivos del Estudio

Objetivos Primarios

Objetivos Secundarios

Centros del Estudio

Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.

Este estudio tiene una ubicación

Reclutando

All India Institute of Medical Sciences

New Delhi, IndiaAbrir All India Institute of Medical Sciences en Google Maps
Suspendido1 Centros de Estudio
HIV-TB | Impact of HIV Infection on Latent TB Among Patients With HIV-TB Co-infection | PatLynk